Estrogen induces apoptosis in a rat prostatic adenocarcinoma: Association with an increased expression of TGF-β1 and its type-I and type- II receptors

International Journal of Cancer

Volumn 67, Issue 4, 1996, Pages 573-579

  Landström, Maréne ^a,c,d   Eklöv, Solveig ^b   Colosetti, Pascal ^c   Nilsson, Sten ^b   Damber, Jan Erik ^a   Bergh, Anders ^a   Funa, Keiko ^c  

^a UMEÅ UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; RECEPTOR SUBTYPE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADENOCARCINOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER TRANSPLANTATION; CASTRATION; CONTROLLED STUDY; ESTROGEN ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ACTIVIN RECEPTORS, TYPE I; ADENOCARCINOMA; ANIMALS; APOPTOSIS; CELL DIVISION; ESTRADIOL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MITOTIC INDEX; ORCHIECTOMY; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, INBRED F344; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029812018     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960807)67:4<573::AID-IJC17>3.0.CO;2-8     Document Type: Article

References (27)

1. CARRUBA, G., PFEFFER, U., FECAROTTA, E., COVIELLO, D.A., D'AMATO, E., LO CASTO, M., VIDALI, G. and CASTAGNETTA, L., Estradiol inhibits growth of hormone-nonresponsive PC3 human prostate cancer cells. Cancer Res., 54, 1190-1193 (1994).
2. CHEIFETZ, S., WEATHERBEE, J.A., TSANG, M.L.S., ANDERSON, J.K., MOLE, J.E., LUCAS, R. and MASSAGUÉ, J., Transforming factor system, a complex pattern of cross-reactive ligands and receptors. Cell, 48, 409-415 (1987).
3. FERRO, M.A., Use of intravenous stilbestrol diphosphonate in patients with prostatic carcinoma refractory to conventional hormonal manipulation. Urol. Clin. N. Amer., 18, 139-143 (1991).
4. FRANZÉN, P., TEN DUKE, P., ICHIJO, H., YAMASHITA, H., SCHULZ, H., HELDIN, C.-H. and MIYAZONO, K., Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell, 75, 681-692 (1993).
5. KYPRIANOU, N., ENGLISH, H.F., DAVIDSON, N.E. and ISAACS, J.T., Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res., 51, 162-166 (1991).
6. KYPRIANOU, N., ENGLISH, H.F. and ISAACS, J.T., Programmed cell death during regression of the PC-82 human prostate cancer following androgen ablation. Cancer Res., 90, 3748-3753 (1990).
7. KYPRIANOU, N. and ISAACS, J.T., Identification of a cellular receptor for transforming growth factor beta in rat ventral prostate and its negative regulation by androgens. Endocrinology, 123, 2124-2131 (1988).
8. LANDSTRÖM, M., BERGH, A., THORNELL, L.-E., VIRTANEN, I. and DAMBER, J.-E., Estrogen treatment in Dunning tumours in castrated rats: qualitative and quantitative morphology. Prostate, 20, 199-211 (1992).
9. LANDSTRÖM, M., BERGH, A., TOMIC, R. and DAMBER, J.-E., Estrogen treatment combined with castration inhibits tumour growth more effectively than castration alone in the Dunning R3327 rat prostatic adenocarcinoma. Prostate, 17, 57-68 (1990).
10. LANDSTRÖM, M., DAMBER, J.-E. and BERGH, A., Estrogen treatment postpones castration-induced dedifferentiationof the Dunning R33327-PAP prostatic adenocarcinoma. Prostate, 25, 10-18 (1994a).
11. LANDSTRÖM, M., DAMBER, J.E. and BERGH, A., Prostatic tumour regrowth after initially successful castration therapy may be related to a decreased apoptotic cell death rate. Cancer Res., 54, 4281-4284 (1994b).
12. MARTIKAINEN, P., KYPRIANOU, N. and ISAACS, J.T., Effect of transforming growth factor-β1 on proliferation and death of rat prostatic cells. Endocrinology, 127, 2963-2968 (1990).
13. MASSAGUÉ, J., Receptors for the TGF-β family. Cell, 69, 1067-1070 (1992).
14. MUIR, G.H., BUTTA, A., SHEARER, R.J., FISHER, C., DEARNALEY, D.P., FLANDERS, K.C., SPORN, M.B. and COLLETTA, A.A., Induction of transforming growth factor beta in hormonally treated human prostate cancer. Brit. J. Cancer, 69, 130-134 (1994).
15. OBERHAMMER, F., PAVELKA, M., SHARMA, S., TIEFENBACHER, R., PURCHIO, T.A., BURSCH, W. and SCHULTE-HERMANN, R., Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor-β1. Proc. nat. Acad. Sci. (Wash.), 89, 5408-5412 (1992).
16. PERRY, R.R., KANG, Y. and GREAVES, B.R., Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells. Brit. J. Cancer, 72, 1441-1446 (1995).
17. REYNISDÓTTIR, I., POLYAK, K., IAVARONE, A. and MASSAGUÉ, J., Kip/Cip and Ink 4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Devel., 9, 1831-1845 (1995).
18. SCHENKEN, J.R., BURNS, E.L. and KAHLE, P.J., The effect of diethylstilbestrol and diethylstilbestrol diproprionate on carcinoma of the prostate gland. II. Cytologic changes following treatment. J. Urol., 48, 99-112 (1943).
19. STRANGE, R., LI, F., SAURER, S., BURKHARDT, A. and FRIIS, R.R., Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development, 115, 49-58 (1993).
20. TAKETAZU, F., KATO, M., GOBL, A., ICHIJO, H., TEN DUKE, P., ITOH, J., KYOGOKU, M., RÖNNELID, J., MIYAZONO, K., HELDIN, C.-H. and FUNA, K., Enhanced expression of transforming growth factor β-s and transforming growth factor-β type-II receptor in the synovial tissue of patients with rheumatoid arthritis. Lab. Invest., 70, 620-630 (1994).
21. WAHL, S.M., HUNT, D.A., WAKEFIELD, L.M., MCCARTHY-FRANCIS, N., WAHL, M.M., ROBERTS, A.B. and SPORN, M.B., Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc. nat. Acad. Sci. (Wash.), 84, 5788-5792 (1987).
22. WANG, C.Y., ESHLEMAN, J.R., WILLSON, J.K.V. and MARKOWITZ, S., Both transforming growth factor-β and substrate release are inducers of apoptosis in a human colon adenoma cell line. Cancer Res., 55, 5101-5105 (1995).
23. WANG, X.-F., LIN, H.Y., NG-EATON, E., DOWNWARD, J., LODISH, H.F. and WEINBERG, R.A., Expression, cloning and characterisation of the TGF-β III receptor. Cell, 67, 797-805 (1991).
24. WYLLIE, A.H., Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metast. Rev., 11, 95-103 (1992).
25. WU, X.W. and LEVINE, A.J., P53 and E2F-1 cooperate to mediate apoptosis. Proc. nat. Acad. Sci. (Wash.), 91, 3602-3206 (1994).
26. YAMASHITA, H., ICHIJO, H., GRIMSBY, S., MOREN, A., TEN DUKE, P. and MIYAZONO, K., Endoglin forms a heteromeric complex with the signalling receptors for transforming growth factor-β. J. biol. Chem., 269, 1995-2001 (1994).
27. YANAGIHARA, K. and TSUMURAYA, M., Transforming growth factor β1 induces apoptotic cell death in cultured human gastric carcinoma cells. Cancer Res., 52, 4042-4045 (1992).